Variability in the definition and reporting of adverse events in suicide prevention trials: An examination of the issues and a proposed solution

Archives of Suicide Research

Volumn 15, Issue 1, 2011, Pages 29-42

  Oquendo, Maria A ^a   Feldman, Sarah ^a   Silverman, Emily ^a   Currier, Dianne ^b   Brown, Gregory K ^c   Chen, Donna ^d   Chiapella, Page ^e   Fischbach, Ruth ^a   Gould, Madelyn ^a   Stanley, Barbara ^a   Strauss, David ^a   Zelazny, Jamie ^f   Pearson, Jane ^g  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e National Institute for Alcohol Abuse and Alcoholism   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

^g NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Adverse events; Safety; Serious adverse events; Study evaluation; Suicide research

Indexed keywords

ARTICLE; BEHAVIOR CONTROL; CLASSIFICATION; EDUCATION; HUMAN; INTERVENTION STUDY; METHODOLOGY; PERSONNEL; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; RESEARCH SUBJECT; RISK ASSESSMENT; STANDARD; SUICIDAL IDEATION; SUICIDE; TREATMENT OUTCOME;

BEHAVIOR CONTROL; GUIDELINES AS TOPIC; HUMANS; INTERVENTION STUDIES; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PSYCHOLOGY; RESEARCH DESIGN; RESEARCH PERSONNEL; RESEARCH SUBJECTS; RISK ASSESSMENT; SUICIDAL IDEATION; SUICIDE;

EID: 79551641049     PISSN: 13811118     EISSN: 15436136     Source Type: Journal    
DOI: 10.1080/13811118.2011.541146     Document Type: Article

References (27)

1. Barach, P., & Small, S. D. (2000). Reporting and preventing medical mishaps: Lessons from non-medical near miss reporting systems. British Medical Journal, 320(7237), 759-763.
2. Brown, G. K., Ten Have, T., Henriques, G. R., Xie, S. X., Hollander, J. E., & Beck, A. T. (2005). Cognitive therapy for the prevention of suicide attempts: A randomized controlled trial. Journal of the American Medical Association, 294(5), 563-570.
3. Califf, R. M., Morse, M. A., Wittes, J., Goodman, S. N., Nelson, D.K., DeMets, D. L., Sugarman, J. (2003). Toward protecting the safety of participants in clinical trials. Controlled Clinical Trials, 24(3), 256-271.
4. Cullen, D. J., Bates, D. W., Small, S. D., Cooper, J. B., Nemeskal, A. R., & Leape, L. L. (1995). The incident reporting system does not detect adverse drug events: A problem for quality improvement. The Joint Commission Journal on Quality Improvement, 21(10), 541-548.
5. Czaja, S. J., Schulz, R., Belle, S. H., Burgio, L. D., Armstrong, N., Gitlin, L. N., Stahl, S. M. (2006). Data and safety monitoring in social behavioral intervention trials: The REACH II experience. Clinical Trials, 3(2), 107-118.
6. De Leo, D., Burgis, S., Bertolote, J. M., Kerkhof, A. J., & Bille-Brahe, U. (2006). Definitions of suicidal behavior: Lessons learned from the WHO/EURO multicentre study. Crisis, 27(1), 4-15.
7. Gandhi, T. K., Seger, D. L., & Bates, D. W. (2000). Identifying drug safety issues: From research to practice. International Journal for Quality in Health Care, 12(1), 69-76.
8. Goldsmith, S. K., Pellmar, T. C., Kleinman, A. M., & Bunney, W. E. (2002). Reducing suicide. A national imperative. Washington, DC: The National Academies Press.
9. Hebert, P. C. (2001). Disclosure of adverse events and errors in healthcare: An ethical perspective. Drug Safety, 24(15), 1095-1104.
10. Hwang, R. W., & Herndon, J. H. (2007). The business case for patient safety. Clinical Orthopaedics and Related Research, 45721-45734.
11. Leape, L. L. (1994). Error in medicine. Journal of American Medical Association, 272(23), 1851-1857.
12. Leape, L. L. (2002). Reporting of adverse events. New England Journal of Medicine, 347(20), 1633-1638.
13. Liauw, W. S., & Day, R. O. (2003). Adverse event reporting in clinical trials: Room for improvement. Medical Journal of Australia, 179(8), 426-428.
14. Mahoney, M. R., & Sargent, D. J. (2007). Adverseevent rates: Journals versus databases. Lancet, 369(9557), 171-172.
15. National Institute of Mental Health. Computer Retrieval of Information on Scientific Projects. (2008). Retrieved from http:/crisp.cit.nih.gov/crisp_query.generate_screen.
16. O'Carroll, P. W., Berman, A. L., Maris, R. W., Moscicki, E. K., Tanney, B. L., & Silverman, M.M. (1996). Beyond the Tower of Babel: A nomenclature for suicidology. Suicide and Life Threatening Behavior, 26(3), 237-252.
17. Office for Human Research Protection (OHRP). (2005). DRAFT Guidance on reporting and reviewing adverse events and unanticipated problems involving risks to subjects or others. Retrieved from http://www.hhs.gov/ohrp/requests/aerg.html.
18. Oquendo, M. A., Stanley, B., Ellis, S. P., & Mann, J. J. (2004). Protection of human subjects in intervention research for suicidal behavior. American Journal of Psychiatry, 161(9), 1558-1563.
19. Petry, N. M., Roll, J. M., Rounsaville, B. J., Ball, S. A., Stitzer, M., Peirce, J. M., Carroll, K. M. (2008). Serious adverse events in randomized psychosocial treatment studies: Safety or arbitrary edicts? Journal of Consulting and Clinical Psychology, 76(6), 1076-1082.
20. Posner, K., Oquendo, M. A., Gould, M., Stanley, B., & Davies, M. (2007). Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. American Journal of Psychiatry, 164(7), 1035-1043.
21. Raisch, D. W., Troutman, W. G., Sather, M. R., & Fudala, P. J. (2001). Variability in the assessment of adverse events in a multicenter clinical trial. Clinical Therapeutics, 23(12), 2011-2020.
22. Rivard, P. E., Luther, S. L., Christiansen, C. L., Shibei, Z., Loveland, S., Elixhauser, A., Rosen, A. K. (2008). Using patient safety indicators to estimate the impact of potential adverse events on outcomes. Medical Care Research and Review, 65(1), 67-87.
23. Santiago, L. M., Debanne, S. M., & Neuhauser, D. (2003). Tracking adverse events in RCTs: Lack of agreement among regulatory institutions. Quality and Safety in Health Care, 12(3), 234-235.
24. Silverman, H. (2007). Ethical issues during the conduct of clinical trials. Proceedings of the American Thoracic Society, 4(3), 180-184.
25. Silverman, M. M., Berman, A. L., Sanddal, N. D., O'Carroll, P. W., & Joiner, T. E. (2007). Rebuilding the tower of Babel: A revised nomenclature for the study of suicide and suicidal behaviors. Part 2: Suicide-related ideations, communications, and behaviors. Suicide and Life-Threatening Behavior, 37(3), 264-277.
26. Terrin, M. L. (2004). Evaluating and implementing data and safety monitoring plans. Journal of Investigative Medicine, 52(7), 459-463.
27. Van Heeringen, C., Jannes, S., Buylaert, W., Henderick, H., De, B. D., & Van, R. J. (1995). The management of non-compliance with referral to out-patient after-care among attempted suicide patients: A controlled intervention study. Psychological Medicine, 25(5), 963-970.